Publications by authors named "Minaki Hamada"
J Alzheimers Dis
June 2024
Article Synopsis
- Alzheimer's disease (AD) is increasingly prevalent due to aging populations, and early diagnosis through serum biomarker peptides is vital for intervention.
- In this study, researchers validated biomarkers that differentiate between mild cognitive impairment (MCI), AD, and cognitively healthy individuals using a new technology called the Dementia Risk Test.
- The findings revealed that three specific peptides—Fibrinogen α chain, Fibrinogen β chain, and Plasma protease C1 inhibitor—showed high sensitivity and specificity, indicating their potential as effective diagnostic tools for AD.
